Treatment of experimental colitis by oral tolerance induction: a central role for suppressor lymphocytes-Reference-Cited by-同舟云学术

Treatment of experimental colitis by oral tolerance induction: a central role for suppressor lymphocytes

Published:2000-04 Issue:4 Volume:95 Page:966-973
ISSN:0002-9270
Container-title:The American Journal of Gastroenterology
language:en
Short-container-title:Am J Gastroenterology

Author:

Ilan Yaron,Weksler-Zangen Sarah,Ben-Horin Shomron,Diment Judith,Sauter Bernhard,Rabbani Elazar,Engelhardt Dean,Roy Chowdhury Namita,Roy Chowdhury Jayanta,Goldin Eran

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Reference46 articles.

1. Inflammatory Bowel Disease

2. A shared and unique epitope(s) on human colon, skin, and biliary epithelium detected by a monoclonal antibody

3. Human colonic intraepithelial and lamina proprial lymphocytes: cytotoxicity in vitro and the potential effects of the isolation method on their functional properties.

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Distinct functions and transcriptional signatures in orally induced regulatory T cell populations;Frontiers in Immunology;2023-10-26

2. Plant life-associated natural products: Algae and mushrooms;Natural Plant Products in Inflammatory Bowel Diseases;2023

3. Oral tolerance to prevent anti-drug antibody formation in protein replacement therapies;Cellular Immunology;2022-12

4. Acute infection with Strongyloides venezuelensis increases intestine production IL-10, reduces Th1/Th2/Th17 induction in colon and attenuates Dextran Sulfate Sodium-induced colitis in BALB/c mice;Cytokine;2018-11

5. An oral administration of a recombinant anti-TNF fusion protein is biologically active in the gut promoting regulatory T cells: Results of a phase I clinical trial using a novel oral anti-TNF alpha-based therapy;Journal of Immunological Methods;2017-07